Differential diagnosis of Alzheimer's disease (AD) and dementia with Lewy bodies (DLB)
remains challenging; currently the best discriminator is striatal dopaminergic imaging …

Introduction The aim of this study was to build a random forest classifier to improve the
diagnostic accuracy in differentiating dementia with Lewy bodies (DLB) from Alzheimer's …

Despite improvements in diagnostic criteria for dementia with Lewy bodies (DLB), the ability
to discriminate DLB from Alzheimer's disease (AD) and other dementias remains …

Objective Current diagnostic criteria for dementia with Lewy bodies (DLB) regard
electroencephalogram (EEG) abnormalities as a supportive feature. It has also been …

Although reports on EEG in dementia with Lewy bodies (DLB) are conflicting, the recent
diagnostic guidelines define EEG abnormalities as being supportive for the diagnosis. We …

Background Biomarkers are being used increasingly to support the diagnosis of dementia
with Lewy bodies (DLB). Novel biomarkers that increase diagnostic specificity of DLB are …

Introduction: Previous studies on electroencephalography (EEG) to discriminate between
dementia with Lewy bodies (DLB) and Alzheimer's disease (AD) have been promising …

Alzheimer disease (AD) and dementia with Lewy bodies (DLB) are common etiologies of
dementia with overlapping clinical features. Our objective was to determine which …

Introduction The goal was to compare subgroups of dementia with Lewy Bodies (DLB) using
neuropathological measures to differentiate 'pure'Lewy body (LB) dementia from 'mixed'DLB …

Background: The clinical diagnostic criteria for dementia with Lewy bodies (DLB) have a low
sensitivity, and there are no generally accepted biomarkers to distinguish DLB from other …